Fundraising Fox
Accent Therapeutics
Founded 2017 · 31 employees on LinkedIn · 16 known investors
Find your way into Accent Therapeutics
Sign up to see every warm intro you have to Accent Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accent Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients. It operates in oncology-focused drug discovery and development.
Investors · 16
How we know: Atlas Venture's portfolio page · a partner's Signal profile · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Droia Ventures's portfolio page · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: The Column Group's portfolio page · a partner's Signal profile · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 6
Funding
SEC filings, press & company announcements$75M disclosed across 1 round · 2024
- $75MSeries CJan 2024 · 3 sources
Mirae Asset Capital Life Science (lead), AbbVie Ventures, Atlas Venture, Bristol Myers Squibb, Droia Ventures, EcoR1 Capital, GV, JJDC, Johnson & Johnson Innovation – JJDC, Inc., Mirae Asset Capital, Mirae Asset Venture Investment, The Column Group, The Mark Foundation for Cancer Research, Timefolio Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Accent Therapeutics do?
- Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients. It operates in oncology-focused drug discovery and development.
- Who are Accent Therapeutics's investors?
- Accent Therapeutics's investors include Atlas Venture, Droia Ventures, EcoR1 Capital, GV (Google Ventures), The Column Group, AbbVie, JJDC, Johnson & Johnson Innovation – JJDC and 2 more.
- How much funding has Accent Therapeutics raised?
- Accent Therapeutics has disclosed $75M raised across 1 round.